The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Apr 2016 15:21

RNS Number : 2549U
Impellam Group plc
05 April 2016
 

 

 

IMPELLAM GROUP PLC

("Impellam", the "Group" or the "Company")

Issue of Equity, Director's Shareholding and Total Voting Rights correction

 

Further to the acquisition of Lorien Limited ("Lorien") which completed in November 2014, Impellam announces that it has today issued a total of 719,344 new ordinary shares of 1p each ("Ordinary Shares") to the vendors of Lorien at a price of 831p per share ("Lorien Consideration Shares"). These shares have been issued to part satisfy the final deferred consideration due, now payable of £11.95 million, in accordance with the terms of the earn-out. Subject to satisfactory conclusions of outstanding claims, an additional cash payment of approximately £0.104 million may be payable to the vendors of Lorien.

As part of the deferred consideration payment, Derek O'Neill, a non-executive director of Impellam and major shareholder of Lorien, and his wife, have been issued an aggregate of 261,481 Lorien Consideration Shares and a cash payment, in aggregate, of approximately £1.9 million. Following the issue of Lorien Consideration Shares, Mr O'Neill will have an interest in 707,570 Ordinary Shares representing approximately 1.4 per cent. of the Company's enlarged issued share capital.

In addition, further to the Company's announcements on 8th and 11th December 2015 concerning the acquisition of Bartech Holding Corporation and the related issue of new Ordinary Shares, it has come to the Company's attention that the number of shares issued was incorrectly stated as 401,866 new Ordinary Shares, when it should have stated that 401,668 new Ordinary Shares were issued. Accordingly, the Company's issued share capital with voting rights following the issue of these should have stated 49,623,027 Ordinary Shares, a difference of 198 Ordinary Shares.

Accordingly an application has been made for 719,146 new Ordinary Shares to be admitted to trading on AIM, representing the Lorien Consideration Shares less 198 Ordinary Shares. The Lorien Consideration Shares are expected to be admitted to trading on AIM ("Admission") on 11 April 2015. Following Admission, the Company's issued ordinary share capital will consist of 50,342,371 Ordinary Shares admitted to trading on AIM.

The above figure of 50,342,371 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries: For further information please contact the appropriate individual below.

Impellam Group plc

Julia Robertson, Chief Executive

Tel: 01582 692658

Darren Mee, Group Finance Director

Tel: 01582 692658

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

 

Nicholas Wells, Mark Connelly

Tel: 020 7397 8900

 

 

 

Impellam Group plc, traded on the AIM (Symbol: IPEL) is a leading provider of managed services and specialist staffing expertise and is primarily based in the UK and North America, with smaller operations in Australasia, Ireland and mainland Europe. Impellam Group plc provides fulfilling jobs to doctors, lawyers, accountants, nurses, teachers, scientists, receptionists, drivers, chefs, administrators, engineers, technology specialists, cleaners, security guards, and manufacturing and warehouse operatives through 18 specialist businesses across a broad range of sectors. Impellam Group plc manage them as teams or individually and help clients build better businesses in a changing world. Impellam Group plc is the 2nd largest recruitment business in the UK, 12th worldwide with over 2,500 Impellam people across over 234 locations worldwide.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESSUFLIFMSEFL
Date   Source Headline
22nd Nov 202311:40 amRNSForm 8.5 (EPT/RI)
22nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
21st Nov 20232:06 pmRNSForm 8.3 - Impellam Group Plc
21st Nov 202310:46 amRNSForm 8.5 (EPT/RI)
21st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
16th Nov 202311:46 amRNSForm 8.3 - Impellam Group PLC
16th Nov 202311:24 amRNSForm 8.5 (EPT/RI)
16th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Nov 20231:33 pmRNSForm 8.3 - Impellam Group Plc
15th Nov 20239:29 amRNSForm 8.5 (EPT/RI)
15th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Nov 202312:36 pmRNSForm 8.3 - Impellam Group Plc
14th Nov 202310:34 amRNSForm 8.5 (EPT/RI)
14th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
13th Nov 202311:51 amRNSForm 8.3 - Impellam Group Plc
13th Nov 202311:39 amRNSForm 8.5 (EPT/RI)
13th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th Nov 202312:16 pmRNSForm 8.3 - Impellam Group Plc
10th Nov 202310:37 amRNSForm 8.5 (EPT/RI)
10th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Nov 202311:45 amRNSForm 8.3 - Impellam Group PLC
8th Nov 20235:46 pmRNSPUSU Extension and Interim Dividend
8th Nov 20234:07 pmRNSExtension of PUSU Deadline
8th Nov 20232:04 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202312:29 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202311:02 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Nov 202310:45 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 202311:18 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 20239:22 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSTransaction in Own Shares & Rule 2.9 Announcement
2nd Nov 202312:09 pmRNSForm 8.3 - Impellam Group PLC
2nd Nov 20239:57 amRNSForm 8.5 (EPT/RI)
2nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20232:21 pmRNSForm 8.3 - Impellam Group PLC
1st Nov 202310:30 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:30 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Oct 202311:28 amRNSForm 8.3 - Impellam Group PLC
30th Oct 202312:35 pmRNSForm 8.3 - Impellam Group PLC
26th Oct 202310:45 amRNSForm 8.5 (EPT/RI)
26th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
25th Oct 20233:41 pmRNSExtension of PUSU Deadline
25th Oct 202311:47 amRNSForm 8.5 (EPT/RI)
25th Oct 202311:17 amRNSForm 8.3 - Impellam Group plc
25th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Oct 202311:07 amRNSForm 8.5 (EPT/RI)
24th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Oct 202311:13 amRNSForm 8.5 (EPT/RI)
17th Oct 202311:38 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.